R. Guan et al., THE EFFECT OF POLYUNSATURATED PHOSPHATIDYL CHOLINE IN THE TREATMENT OF ACUTE VIRAL-HEPATITIS, Alimentary pharmacology & therapeutics, 9(6), 1995, pp. 699-703
Background: Polyunsaturated phosphatidyl choline is a preparation ofte
n advocated for diseases of the liver. Methods: In a randomized open c
ontrolled trial, a preparation of polyunsaturated phosphatidyl choline
, at a dose of 900 mg orally daily, was given to 22 patients with acut
e viral hepatitis, A control group of 25 patients was not treated. Res
ults: Serial serum bilirubin and alanine amino transferase levels were
measured up to 12 weeks. The falls in their levels after 2 and 5 week
s. and the lengths of time to their normalization, were not significan
tly different in the treated group compared to the control group. Conc
lusion: The results indicated that polyunsaturated phosphatidyl cholin
e had no beneficial effect on the course of acute viral hepatitis.